This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.

How to use Zincas forte

Package Leaflet: Information for the User

ZINCAS FORTE, 27 mg zinc ions, tablets

Zinci hydroaspartas

Read the package leaflet carefully before using the medicine, as it contains important information for the patient.

This medicine should always be used exactly as described in the package leaflet for the patient or as directed by a doctor, pharmacist, or nurse.

This leaflet should be kept in case it needs to be read again.
If advice or additional information is needed, a pharmacist should be consulted.
If the patient experiences any side effects, including any possible side effects not listed in the leaflet, they should inform their doctor, pharmacist, or nurse. See section 4.
If there is no improvement after 30 days or the patient feels worse, they should contact their doctor.

Table of Contents of the Leaflet

1. What is Zincas Forte and what is it used for
2. Important information before using Zincas Forte
3. How to use Zincas Forte
4. Possible side effects
5. How to store Zincas Forte
6. Package contents and other information

1. What is Zincas Forte and what is it used for

Zincas Forte is a medicine containing zinc.
Zincis a microelement. It regulates the production of growth hormone and sex hormones (it is necessary for the production of sperm and egg cells). It reduces the body's susceptibility to infections and allergies. It affects the proper secretion of insulin by the pancreas.
A zinc deficiency can cause: skin disorders, gastrointestinal disorders, nervous system disorders, immune system disorders, and bone system disorders. A significant zinc deficiency can cause dwarfism and underdevelopment of the sex organs.

Indications for use:

supplementing zinc deficiency in the body.

2. Important information before using Zincas Forte

When not to use Zincas Forte

if the patient is allergic (hypersensitive) to zinc hydroaspartate dihydrate or any of the other ingredients of this medicine (listed in section 6),
if the patient has kidney failure,
if the patient is being treated with antibiotics or other medicines (see the section "Zincas Forte and other medicines").

Warnings and precautions

A dose higher than recommended may cause diarrhea.

Children

Zincas Forte should not be used in children under 15 years of age.

Zincas Forte and other medicines

The patient should inform their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Zincas Forte should not be used at the same time as the following medicines:

antibiotics from the tetracycline group (e.g., doxycycline), as zinc reduces their absorption,
containing acetylsalicylic acid,
non-steroidal anti-inflammatory drugs (NSAIDs), e.g., ibuprofen, indomethacin,
diuretics, e.g., hydrochlorothiazide,
corticosteroids, also known as steroids, e.g., hydrocortisone,
medicines and dietary supplements containing calcium, iron, and copper, as they reduce zinc absorption,
chelating agents, e.g., penicillamine - a medicine used to treat, among other things, lead or copper poisoning.

Using Zincas Forte with food and drink

The medicine should be taken after a meal, with a glass of water (see section 3).
Zincas Forte should not be taken at the same time as dairy products (milk and its derivatives). These products reduce zinc absorption.

Pregnancy, breastfeeding, and fertility

If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Zincas Forte should not be used during pregnancy and breastfeeding.

Driving and using machines

There is no data on the harmful effects of Zincas Forte on the ability to drive and use machines.
Zincas Forte contains sucrose. One tablet contains 12.24 mg of sucrose. This should be taken into account in patients with diabetes. If the patient has previously been diagnosed with intolerance to certain sugars, they should consult their doctor before taking the medicine.

3. How to use Zincas Forte

This medicine should always be used exactly as described in the package leaflet for the patient or as directed by a doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist.

Use in adults and adolescents over 15 years of age

Recommended dose:
1 tablet per day.
Zincas Forte should be taken orally, after a meal, with a glass of water.
If the symptoms do not improve after 30 days of using the medicine, the patient should contact their doctor.

Using a higher dose of Zincas Forte than recommended

In case of taking a higher dose of the medicine than recommended, the patient should consult their doctor or pharmacist.
Symptoms of Zincas Forte overdose (listed in section 4) may occur.

Missing a dose of Zincas Forte

In case of missing a dose, the patient should take the medicine as soon as possible. They should not take a double dose to make up for the missed dose.

4. Possible side effects

Like all medicines, Zincas Forte can cause side effects, although not everybody gets them.
When used as directed, no side effects have been observed.
Larger doses of the medicine may cause side effects, such as:

nausea, abdominal pain, diarrhea,
metallic taste in the mouth,
headache. Long-term use of Zincas Forte may cause copper deficiency and anemia.

Reporting side effects

If the patient experiences any side effects, including any possible side effects not listed in the leaflet, they should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.

5. How to store Zincas Forte

The medicine should be stored out of sight and reach of children.
Store in a temperature below 25°C.
Store in the original packaging to protect from light and moisture.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of the given month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer use. This will help protect the environment.

6. Package contents and other information

What Zincas Forte contains

The active substance of the medicine is zinc hydroaspartate dihydrate. One tablet contains: 27 mg of zinc ions in the form of 150 mg of zinc hydroaspartate dihydrate.
The other ingredients are: potato starch, sucrose, talc, magnesium stearate, dextrin, sodium carboxymethyl cellulose (type C), microcrystalline cellulose.

What Zincas Forte looks like and what the package contains

Zincas Forte is a white, round, flat tablet on both sides.
Available packaging: a container containing 50 tablets in a cardboard box.

Marketing authorization holder and manufacturer

Pharmaceutical Company Farmapol Sp. z o.o.
ul. Święty Wojciech 29
61-749 Poznań
tel.: +48 61 852 63 53
e-mail: [email protected]
To obtain more detailed information, the patient should contact the representative of the marketing authorization holder.
Information for the blind and visually impaired:the content of the leaflet is available on the free phone number: 0800 706 848.
Date of last update of the leaflet:06/2021

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

seasonal and perennial allergies
allergic rhinitis and chronic nasal symptoms
asthma and breathing difficulties
food and medication allergies
urticaria, atopic dermatitis and skin reactions
recurrent infections in children
sports-related health questions
general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.